Elon Musk is Looking for a Neuralink Clinical Trial Director; Does It Mean It Has A Toxic Work Environment?

Elon Musk and Neuralink are looking for a new Clinical Trial Director. According to an online job posting, the new position entails duties for a practical approach to the company's renowned brain implants, which aim to meld AI and humans.

On the other hand, this new listing shows that the firm can conduct human studies.

(Photo: Unsplash)
Robot Uprising is Inevitable as AI Would Likely Not Follow Humans' Value Systems That Shaped Society, Neuralink Co-Founder Said

Elon Musk, Neuralink is Looking For a Clinical Trial Director Job

Neuralink has a new job opening for a Clinical Trial Director, and it's the talk of the town as to what the company's next steps will be for its technology. Elon Musk's renowned neuroscience firm is currently looking for a specialist to administer brain implants while the company is still in the experimental stage.

According to the job description, the new director will work closely with the US Food and Drug Administration (FDA) on the licensing of the implants available shortly. For the time being, the hunt is only focused on the director's arrival rather than volunteers for the human brain implant technology.

Bloomberg also mentioned that the director would also work with Neuralink participants. However, it is unclear whether this is for the implants.

ALSO READ: Elon Musk's Neuralink to Start Implanting Brain Chips for Humans Trials in 2022 Aiming to Help Paralyzed People

Human trials are still in limbo for Neuralink. Still, rumors suggest that they are on the verge of becoming a reality, according to a job opportunity for a director of clinical trials.

Musk and Neuralink's vision will be realized shortly, especially in terms of the company's offerings. Initially, the CEO spoke of a "symbiosis" between technology and people, thanks to the implants. With the assistance of technology, brain implants will improve a person's overall performance.

Employees Leaving Neuralink

Last year, the public saw the departure of Neuralink co-founder Max Hodak, who stated that he was seeking other chances. Hodak's exit from the firm isn't a harsh pill to swallow after putting it totally in Musk's hands, and it demonstrates a commitment to Neuralink's innovation and upcoming role as a healthcare provider.

✨Some personal news:✨ I am no longer at Neuralink (as of a few weeks ago). I learned a ton there and remain a huge cheerleader for the company! Onward to new things.
— Max Hodak (@maxhodak_) May 1, 2021

Ex-employees told Stat News in 2020 that the clinical trials director post would put them in a chaotic scientific atmosphere where they would be pressured to achieve scientific advances on unrealistically short timescales. They'd have to deal with Musk's repeated claims of timetables that haven't yet materialized, as well as his publicly stated objectives that continue to exceed what experts consider to be acceptable expectations for brain-machine interfaces. Nothing like that is mentioned in the job description, The Verge said.

Nonetheless, the company's hunt for its new clinical trial director is significant because it signals only one thing: it is ready to move forward with the implants. However, the technology did not demonstrate its preparedness for the implantation, leaving the public to guess if the experiments will be conducted on people or animals, as it did the previous time.